BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 bln doses

Frankfurt: BioNTech said on Tuesday that it and partner Pfizer would increase manufacturing capacity of their COVID-19 vaccine to 2.5 billion doses by the end of 2021, unveiling for the first time projected sales of close to 10 billion euros ($11.73 billion) from the product this year.

Pfizer previously said the two partners would likely produce between 2.3 billion and 2.4 billion doses this year. BioNTech cited its new facility in the German city of Marburg and an expansion of the pair's network of third-party manufacturers and suppliers as drivers behind the larger volumes.